U2Bio Co., Ltd. (KOSDAQ:221800)
3,125.00
+25.00 (0.81%)
At close: Aug 14, 2025, 3:30 PM KST
U2Bio Market Cap
U2Bio has a market cap or net worth of 35.27 billion as of August 15, 2025. Its market cap has decreased by -26.81% in one year.
Market Cap
35.27B
Enterprise Value
1.41B
Revenue
25.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,125.00
Market Cap Chart
Since April 3, 2017, U2Bio's market cap has increased from 28.86B to 35.27B, an increase of 22.24%. That is a compound annual growth rate of 2.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 35.27B | 17.26% |
Dec 30, 2024 | 30.08B | -49.53% |
Dec 28, 2023 | 59.60B | 20.84% |
Dec 29, 2022 | 49.32B | -12.03% |
Dec 30, 2021 | 56.07B | 276.76% |
Dec 30, 2020 | 14.88B | -39.54% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Apr 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 467.88T |
SK hynix | 190.88T |
LG Energy Solution | 92.20T |
Samsung Biologics | 73.52T |
Hyundai Motor Company | 47.53T |
Hanwha Aerospace | 45.17T |
HD Hyundai Heavy Industries | 42.34T |
Doosan Enerbility | 41.95T |